Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

This was an exploratory analysis comparing the safety and efficacy of tocilizumab monotherapy with those of tocilizumab in combination with disease-modifying anti-rheumatic drugs (DMARDs). Data were from a single-arm, nonrandomized, open-label, 24-week study in patients with rheumatoid arthritis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bykerk, Vivian P., Östör, Andrew J. K., Alvaro-Gracia, José, Pavelka, Karel, Ivorra, José Andrés Román, Graninger, Winfried, Bensen, William, Nurmohamed, Michael T., Krause, Andreas, Bernasconi, Corrado, Aassi, Maher, Sibilia, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2015
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348534/
https://www.ncbi.nlm.nih.gov/pubmed/25604316
http://dx.doi.org/10.1007/s10067-014-2857-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348534/
https://www.ncbi.nlm.nih.gov/pubmed/25604316
http://dx.doi.org/10.1007/s10067-014-2857-y

Ejemplares similares